comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 22:26:33 - browse：63342

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Stop the failed accountable care organization experiment

knowledge

WSS

WATCH: Why do bright lights make us see spots?

White House touts steps to stem shortages of cancer treatments

Telehealth for opioid use disorder is lifesaving

FDA proposes changes to key medical devices approval pathway

Long Covid needs a new name — and a new frame

Positive childhood experiences can help future health

entertainment

comprehensive

knowledge

Apple is now the first public company to be valued at $3 trillion

Pig kidney works a record two months in donated body

How one medical school became remarkably diverse

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Virginia high school admissions case could be legal follow

Colonoscopy prep: Liquid

State Dept. review finds Biden bears some blame for Afghanistan failures

UnitedHealth increases loan offers after Change Healthcare outage

Wildfire smoke exposes gaps in outdoor worker protections

Food makers to regulators: Ultra

leisure time

Regeneron agrees to White House price limits on anti

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

U.K. researchers warn about biases in medical devices, algorithms

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Readout Newsletter: Bluebird, CVS, Contineum

UnitedHealth increases loan offers after Change Healthcare outage

focus

focus

knowledge

Wikipedia